Integral Health Asset Management, LLC Viridian Therapeutics, Inc.\De Transaction History
Integral Health Asset Management, LLC
- $850 Million
- Q3 2024
A detailed history of Integral Health Asset Management, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 250,000 shares of VRDN stock, worth $4.98 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
250,000Holding current value
$4.98 Million% of portfolio
0.67%Shares
1 transactions
Others Institutions Holding VRDN
# of Institutions
181Shares Held
76.7MCall Options Held
581KPut Options Held
439K-
Black Rock Inc. New York, NY4.77MShares$95.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$88.1 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$77.4 Million9.15% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.75MShares$74.8 Million3.15% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.45MShares$68.7 Million12.74% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $795M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...